Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Active not recruiting 15Recruiting 6Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 81Bevacizumab 66Drug Therapy 64Cisplatin 62Magnetic Resonance Spectroscopy 61Carboplatin 60Gemcitabine 56Radiotherapy 55Cyclophosphamide 55pembrolizumab 52Oxaliplatin 50Capecitabine 50toripalimab 42Paclitaxel 41tislelizumab 40Standard of Care 40Biopsy 38fludarabine 36Fluorouracil 35venetoclax 32Blood Specimen Collection 31Injections 30Immune Checkpoint Inhibitors 30anlotinib 29Nivolumab 29Irinotecan 29Docetaxel 29Surgical Procedures, Operative 28Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Erlotinib Hydrochloride × 1 year × Clear all
NCT04172779 2026-05-01

ECHO-B

University of Texas Southwestern Medical Center

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡